Director/PDMR Shareholding

Primary Health Properties PLC

28 October 2026

 

Primary Health Properties PLC

("PHP" or the “Company”),

Director/PDMR Shareholding

Primary Health Properties PLC

Director Dealings - LTIP

Primary Health Properties PLC, announces that the Remuneration Committee has approved the following awards of nil-cost options under the Company’s 2021 Long-term Incentive Plan (“LTIP”) to Directors as follows:

Director	Number of shares under option
Mark Davies	1,400,871
Richard Howell	857,843

The number of nil-cost options were calculated by reference to a price of £0.9180, being the average of the closing middle market quotations for the Company’s ordinary shares on 22, 23 and 26 October 2026. 

The nil-cost options will vest subject to the attainment of performance conditions measured over three years to 31 December 2028.  The remuneration committee has the discretion to adjust the awards downwards at vesting for malus reasons.  Details of the operation of the LTIP are set out in the Company’s 2025 Report and Accounts.

Details of the transactions referenced above are included below in accordance with the under Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name	Mark Davies
2	Reason for notification
(a)	Position/Status	Chief Executive Officer
(b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name	Primary Health Properties PLC
(b)	LEI	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument and identification code	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of transaction	Award of nil-cost options over the Company’s ordinary shares
(c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil cost	1,400,871
(d)	Aggregated Information	Single transaction: N/A
(e)	Date of transaction	27 October 2026
(f)	Place of transaction	N/A

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name	Richard Howell
2	Reason for notification
(a)	Position/Status	Chief Financial Officer
(b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name	Primary Health Properties PLC
(b)	LEI	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument and identification code	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of transaction	Award of nil-cost options over the Company’s ordinary shares
(c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil cost	857,843
(d)	Aggregated Information	Single transaction: N/A
(e)	Date of transaction	27 October 2026
(f)	Place of transaction	N/A

For further information

Mark Davies CEO Richard Howell CFO

Primary Health Properties PLC    Primary Health Properties PLC

David Purcell Investor Relations

Primary Health Properties PLC

T: [phone]

E: [e-mail]

Sodali & Co Financial PR

Elly Williamson/Madeleine Gordon-Foxwell

T: [phone]

E: [e-mail]

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

END